Treatment Action Group

Landmark TB trials results published in New England Journal of Medicine

A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.

Read More →

Call for applications! Malaria, hepatitis C, and latent TB infection long-acting technologies community advisory board

TAG and AfroCAB are inviting applications from treatment activists and community leaders for a new cross-disease long-acting technologies community advisory board. The deadline to apply is 21 May 2021.

Read More →

TAG vacancy: EU and UK TB R&D advocacy consultant

Treatment Action Group (TAG) is seeking a consultant to advance strategic policy-advocacy and resource mobilization efforts for TB research and development (R&D) in the context of the European Union (EU) and UK global development cooperation.

Read More →

Webinar: Demanding a higher standard of TB care in EECA - materials now available online

On 1 April 2021, Treatment Action Group (TAG) and the TB Europe Coalition co-hosted a webinar, Demanding a higher standard of TB care in Eastern Europe and Central Asia (EECA). The webinar marked the launch of TAG’s TB Activist’s Guides recently translated to Russian and featured speakers who discussed policy gaps and advocacy strategies for activists to demand access to the highest standard of care for TB diagnosis, treatment, and prevention in EECA.

Read More →

TAG online training course: TB Preventive Treatment | Fundamentals for Activists!

For the third year, Treatment Action Group (TAG), with support from the IMPAACT4TB project, is organizing a self-guided Moodle online training course (2 May - 6 June 2021), TB Preventive Treatment | Fundamentals for Activists!, open to any members of TB civil society and communities. The course equips activists with everything they need to know to advocate for the highest-attainable standard of TB preventive treatment.

Read More →

Webinar: Demanding a higher standard of TB care in EECA

On Thursday, April 1, 2021, at 8:00 AM EDT / 2:00 PM CEST, Treatment Action Group (TAG) and TB Europe Coalition (TBEC) will co-host a webinar, “Demanding a Higher Standard of TB Care in Eastern Europe and Central Asia (EECA).”

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AHD in 2021 PEPFAR COPs - webinar materials now available online

On 21 January 2021, Treatment Action Group and partners conducted a webinar on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and advanced HIV disease (AHD).

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and advanced HIV disease in 2021 PEPFAR COPs

TB and viral hepatitis co-infections and advanced HIV disease (AHD) put the lives of people living with HIV at risk, and interventions to address these must be prioritized by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and reflected in its funding allocations. The development of FY2021 Country Operational Plans (COPs) provides a critical opportunity for advocates to ensure that the latest developments in preventing, diagnosing, and treating co-infections and AHD are implemented within PEPFAR programs.

Read More →

New TAG report: Funding for TB research in 2019 nears half of global target

The report — Tuberculosis Research Funding Trends, 2005–2019 — presents new data on 2019 funding for TB research and development and analyzes trends in investment since 2005.

Read More →

TAG's 2020 Pipeline Report: TB chapters released

Treatment Action Group (TAG) launches newly available TB chapters of its 2020 Pipeline Report.

Read More →

Page 1 of 17 · Total posts: 10

1 2 Last→